Texas Cardiology Associates of Houston
Welcome,         Profile    Billing    Logout  
 6 Trials 
23 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kutyifa, Valentina
NCT02270840: Budapest Upgrade CRT Study (Version 009-4.1)

Completed
N/A
360
Europe, RoW
CRT-D
Semmelweis University Heart and Vascular Center, University of Rochester, Sheba Medical Center, Pharmahungary Group
Cardiomyopathy
08/22
08/22
MADIT S-ICD, NCT02787785: Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Completed
N/A
40
Europe, US, RoW
Subcutaneous Implantable Cardioverter Defibrillator
Boston Scientific Corporation, University of Rochester
Tachycardia, Diabetes Mellitus, Cardiovascular Disease
06/23
06/23
OPT-BB WOMEN, NCT04504188: Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator

Recruiting
N/A
300
US
Heart Rate Monitor Enhanced Treatment Optimization, LifeVest Wearable Cardioverter Defibrillator
Zoll Medical Corporation
Cardiomyopathies, Heart Failure
09/24
12/24
BIO-LIBRA, NCT03884608: Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Completed
N/A
1000
US
Biotronik, Inc., University of Rochester
Cardiomyopathies, Gender, Implantable Defibrillator User
11/24
11/24
A-SPIRE-HF, NCT04550052: A-SPIRE Heart Failure: Utilizing Health Tags to Identify Patients at Risk for Hospital Readmissions

Active, not recruiting
N/A
36
US
University of Rochester, Spire, Inc.
Heart Failure
12/26
12/26
Sayfo, Sameh
RESTOR-1, NCT04663867: AngioSafe Peripheral CTO Crossing System Study ( Study)

Completed
N/A
133
US
AngioSafe Peripheral CTO Crossing System
AngioSafe, Inc., Veranex, Inc.
Peripheral Artery Occlusion, Peripheral Arterial Disease
04/23
06/23
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
OSPREY ILIAC, NCT02793492: Misago® RX Self-expanding Peripheral Stent for Common And/or External Iliac Artery

Active, not recruiting
N/A
75
US
Misago® RX Self-expanding Peripheral Stent
Terumo Medical Corporation
Iliac Artery Stenosis
03/25
09/26
EspritBTKPAS, NCT06656364: Esprit BTK Post-Approval Study

Recruiting
N/A
200
US, RoW
Esprit BTK System
Abbott Medical Devices
Chronic Limb-Threatening Ischemia
04/27
05/29
NCT05132361: SELUTION4SFA Trial

Recruiting
N/A
300
Europe, US, RoW
SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA)
MedAlliance, LLC, NAMSA, Cordis Corporation
Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
08/25
12/29
NCT06062329: SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Recruiting
N/A
150
US
Symphony Thrombectomy System
Imperative Care, Inc.
Acute Pulmonary Embolism, Thromboembolism, Emboli, Pulmonary, Thrombosis, Thrombus; Embolism, Embolism, Cardiovascular Diseases, Vascular Diseases
03/25
04/25
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Recruiting
N/A
268
US
Aortix System, Aortix Pump
Procyrion
Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive
07/25
12/25
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
NCT06055920: The PEERLESS II Study

Recruiting
N/A
1200
Europe, Canada, US
FlowTriever System, Anticoagulation Agents
Inari Medical
Pulmonary Embolism
07/26
07/26
Abo-Auda
OPT-BB WOMEN, NCT04504188: Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator

Recruiting
N/A
300
US
Heart Rate Monitor Enhanced Treatment Optimization, LifeVest Wearable Cardioverter Defibrillator
Zoll Medical Corporation
Cardiomyopathies, Heart Failure
09/24
12/24
Salazar, Robert
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Salazar
NCT05603832: A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

Active, not recruiting
3
151
US
F14, 0.25 % Bupivacaine HCl, Acetaminophen, Methocarbamol
Arthritis Innovation Corporation, Allucent
Post Operative Pain
11/23
08/24
OPT-BB WOMEN, NCT04504188: Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator

Recruiting
N/A
300
US
Heart Rate Monitor Enhanced Treatment Optimization, LifeVest Wearable Cardioverter Defibrillator
Zoll Medical Corporation
Cardiomyopathies, Heart Failure
09/24
12/24
Thukral, Nandish
ECP Study, NCT05334784: Impella () and Impella ECP Continued Access Protocol

Enrolling by invitation
N/A
556
US
Impella ECP
Abiomed Inc.
High-Risk Percutaneous Coronary Intervention
12/25
12/26
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Lavigne, Paul
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II

Recruiting
N/A
380
Canada, US
Arm 1: treatment with Neovasc Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry
Neovasc Inc., Shockwave Medical, Inc.
Refractory Angina
06/25
12/28
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27

Download Options